MILPHARM ApS: Financial statements 2020
CVR: 35814159
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
MILPHARM ApS (CVR 35814159) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -9,649 and a net result of DKK 274,792 compared with DKK 90,967 the year before. Equity in the 2020 report amounted to DKK 439,188. The solvency ratio was 47.7%.
- Gross Profit
- DKK -9,649
- Profit/Loss
- DKK 274,792
- Equity
- DKK 439,188
- Total Assets
- DKK 921,344
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -10 t. | 275 t. | 439 t. | 0 |
| 2019 | - | -8 t. | 91 t. | 164 t. | 0 |
| 2018 | - | -8 t. | -86 t. | 73 t. | - |
| 2017 | - | -7 t. | -10 t. | 160 t. | - |
| 2016 | - | -7 t. | 39 t. | 170 t. | - |
Official annual report
How creditworthy is MILPHARM ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout MILPHARM ApS
MILPHARM ApS was a Danish company of the type Anpartsselskab based in Slagelse, founded in 2014. The company has been dissolved on 24 June 2022. The company was registered under the industry Investeringsselskaber. According to the 2021 annual report, the company had an average of 0 employees. In 2021, the company reported a gross profit of DKK -1,867 and a net result of DKK 175,681 compared with DKK 274,792 the year before. Equity in the 2021 report amounted to DKK 614,869.